Related Experiment Video
Updated: Jun 18, 2026
05:04
An Electrophysiology Protocol to Measure Reward Anticipation and Processing in Children
Published on: October 4, 2018
Drug provocation tests in children: Indications and interpretation
1Málaga Children's Hospital, Spain. joseluisch@hotmail.com
Allergologia Et Immunopathologia
|December 1, 2009
Summary
Drug provocation tests in children are complex. This review covers key aspects, including pediatric vs. adult differences, reaction mechanisms, testing procedures, and indications for these essential diagnostic evaluations.
Area of Science:
- Pediatric Allergy and Immunology
- Clinical Pharmacology
Background:
- Drug provocation tests (DPTs) are crucial for diagnosing drug hypersensitivity in children.
- These tests present unique challenges in pediatric populations compared to adults.
Purpose of the Study:
- To review the critical aspects of performing drug provocation tests in children.
- To highlight differences between pediatric and adult DPTs.
- To provide guidance on indications and methodology.
Main Methods:
- Review of existing literature and clinical guidelines on DPTs in children.
- Analysis of mechanisms underlying drug reactions.
- Description of standardized DPT procedures.
Main Results:
- Key differences in drug metabolism and immune responses exist between children and adults.
- Specific protocols are necessary for safe and accurate DPTs in pediatric patients.
- Clear indications guide the appropriate use of DPTs.
Conclusions:
- Drug provocation testing in children requires specialized knowledge and careful execution.
- Understanding pediatric-specific factors is vital for accurate diagnosis and patient safety.
- This review provides a comprehensive guide for clinicians performing DPTs in pediatric populations.
Related Concept Videos
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...